LC-MS - Blogging About What's Possible

Recent posts

BioAccord System with ACQUITY Premier: Some Things Work Better Together

By September 13, 2021

Combining BioAccord, our most capable MS detection platform, with ACQUITY Premier UPLC, our highest performance LC system, to demonstrate superior performance.

Categories: Pharmaceutical
Tags: , , , , , , , , ,

Global Collaboration Aids in the Fight Against COVID-19

By March 22, 2021

The worldwide coronavirus pandemic has changed the way that scientists and companies work. Learn how the Waters COVID-19 Innovation Response Team enabled the critical collaboration and pooling of expertise that enabled fast and safe vaccine development.

Categories: COVID-19, Technologies
Tags: , , , ,

Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM

By March 18, 2021
LC-MS workflows for peptide MAM

The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , , , , ,

Embracing Analytical Techniques Into Regulated Laboratories

By March 2, 2021
biopharma compliance

To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.

Categories: Pharmaceutical, Technologies
Tags: , , , ,

Comprehending COVID-19: How Consumables Can Increase LC-MS/MS Sensitivity

By January 19, 2021

During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological… Read more >

Categories: Chemical, COVID-19, Technologies
Tags: , , , , ,

Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis

By December 11, 2020

Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Boosting Biopharma Productivity with Routine LC-MS

By December 1, 2020

As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Ready for What’s Next in Your Lab?

By October 23, 2020

In this series, we review considerations for keeping your lab at the forefront of science. As you adjust to living and working in a pandemic and anticipate future global and geopolitical events, Waters remains dedicated… Read more >

Categories: General, Technologies
Tags: ,

Addressing the Mystery of Sample Loss

By September 24, 2020

Many years ago, I was hired by a biopharma company to develop analytical methods for therapeutic oligonucleotides. When a new colleague warned me about sample loss on LC columns I looked at him with skepticism.… Read more >

Categories: Columns, MaxPeak Premier Solutions
Tags: , ,

More than a slogan, bioharmonization is a unifying principle that aims to enhance productivity

By July 23, 2019

In January of 2018, Waters kicked off its global Bioharmonization campaign with a blog post and video release, laying out a vision for how the Biopharmaceutical industry can achieve accelerated development and improved quality while… Read more >

Categories: Pharmaceutical
Tags: ,